(Q24305000)

regulation of systemic arterial blood pressure by renin-angiotensin

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

circulatory system

1 reference

Cardiology and cardiovascular medicine

inferred from title

1 reference

DOI

10.1161/01.CIR.53.3.400

https://api.crossref.org/works/10.1161/01.CIR.53.3.400

22 December 2022

author name string

J. Sancho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A174834

22 December 2022

R. Re

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A174834

22 December 2022

J. Burton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A174834

22 December 2022

A. C. Barger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A174834

22 December 2022

E. Haber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A174834

full work available at URL

22 December 2022

language of work or name

English

0 references

publication date

March 1976

0 references

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.53.3.400

1 reference

DOI

10.1161/01.CIR.53.3.400

https://api.crossref.org/works/10.1161/01.CIR.53.3.400

22 December 2022

0 references

53

0 references

issue

3

0 references

page(s)

400-5

0 references

cites work

Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

A simplified radioimmunoassay for plasma aldosterone employing an antibody of unique specificity.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Circulating angiotensin-II and aldosterone levels during dietary sodium restriction

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Competitive inhibitors of renin. Inhibitors effective at physiological pH

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Conversion of angiotensin I to angiotensin II.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Fate of angiotensin I in the circulation

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Metabolism of the angiotensins in isolated perfused tissues

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Some properties of angiotensin converting enzyme in the lung in vivo

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

The role of angiotensin in the cardiovascular and renal response to salt restriction.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Inhibition of angiotensin I converting enzyme by venom peptides

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Angiotensin. II. Important role in the maintenance of arterial blood pressure.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and normotensive rats

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Inhibition of renin secretion by systemic and intrarenal angiotensin infusion

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Effect of angiotensin II and its nonpressor derivatives on renin secretion

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Inhibition of angiotensin conversion and prevention of renal hypertension

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Adrenocortical steroidogenesis: studies on the mechanism of action of angiotensin and electrolytes

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Inhibition of renin secretion by angiotensin. II.

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

The effect of angiotensin on renin production and release in vitro

1 reference

https://api.crossref.org/works/10.1161%2F01.CIR.53.3.400

7 January 2021

Identifiers

DOI

10.1161/01.CIR.53.3.400

0 references